glp 1 agonist clinical trials Outcomes with GLP-1 Receptor Agonists in Patients with Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled | Drugs GLP-1 Agonists: A Comprehensive Overview

This suggests that the GLP-1 findings are unlikely to be an artifact of the studys design.

6 Conclusion In conclusion, GLP-1, initially identified as an intestinal insulin-secreting molecule, exhibits multifaceted effects beyond blood sugar control, showing promise in enhancing cognitive function

With regards to neurodegenerative diseases such as AD and PD, the literature has demonstrated the inhibitory effects of GLP-1 on pro-inflammatory cytokines such as TNF-alpha and IL-1betatwo notorious small molecules identified in the microglial-mediated injury observed in said diseases processes

Available from: 5

PMID 24571751

284.Meng Y., Bai H., Wang S., Li Z., Wang Q., Chen L